
Sign up to save your podcasts
Or


Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.
By The Motley Fool4.7
16041,604 ratings
Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.

3,230 Listeners

1,492 Listeners

806 Listeners

941 Listeners

529 Listeners

1,177 Listeners

2,179 Listeners

825 Listeners

1,428 Listeners

1,046 Listeners

9,650 Listeners

196 Listeners

822 Listeners

81 Listeners

582 Listeners

1,000 Listeners

50 Listeners